The challenge of creating labels for investigational drugs is mounting as more countries sign on to participate in clinical trials. Delays in translating and approving clinical labels—a process that averages about 120 business days can prevent clinical trials from starting on time and threaten to derail development timelines.
Our Clinical Label Services team is setting the pace for improved translation management with the use of ATLAS℠ (Alternative Translation and Label Approval System). ATLAS—the only system available to address the full spectrum of label development, from text translation and approval through label manufacturing.
Download this ebook to learn about the challenges of translating and approving label text, and how an approved phrase library can reduce label timelines, improve quality, and assure regulatory compliance.